微 信 题 库 搜 索
医学论文
期刊分类
国 家 级 省级期刊 北大核心
浙 江 省 科技核心 CSCD期刊
期刊工具
期刊知识 写作指导 论文投稿
论文检测 推荐期刊 录用通知
各省动态
北京 天津 河北
上海 湖北 江苏
浙江 安徽 更多省份
 医学全在线 > 医学论文 > SCI期刊 > 正文
IMMUNOLOGY LETTERS
if:2.367 更新:2015/1/31 字体:

IMMUNOLOGY LETTERS
影响因子: 2.367
I S S N: 0165-2478
出 版 社: Elsevier/North-Holland Biomedical Press.
出 版 地: Amsterdam
出版国家: Netherlands
刊  期: 月刊
创刊时间: 1979
语  种: 英文
审稿周期: 约1.0个月
中科院分区: 4
投稿命中率: 约50%
国外数据库收录: IM
中国收录文章数:
5年影响因子: 2.557
研究领域: 免疫学
官方链接: http://www.sciencedirect.com/science/journal/01652...
投稿须知: http://www.sciencedirect.com/science/journal/01652...

期刊介绍:

Immunology Letters provides a vehicle for the speedy publication of full-length and short articles, Rapid Notes, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings. Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion. Within a reference section, new mRNA sequences with unknown function, expressed sequence tags with tissue distribution and novel monoclonal antibody descriptions are considered for publication

相关文章
 浙江省最新卫生高级职称资格评审刊物名录(
 医学论文投稿官网注意事项汇总
 2014年中国科技统计源论文期刊目录汇总
 四川省合法期刊/A类期刊/B类期刊查询
 论文发表期刊在线查询操作步骤图文详解版
 重庆市卫生高级职务任职资格申报评审条件(
   触屏版       电脑版       全站搜索       网站导航   
版权所有:医学全在线(m.med126.com)
网站首页
频道首页
在线咨询
返回顶部